Stay updated with breaking news from Dermtech Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
- Trust 2 Study confirms negative predictive value of 99.7% for the foundational gene expression assay - Optional TERT promoter mutation testing does not significantly alter sensitivity, NPV or...
- Trust 2 Study demonstrated powerful clinical utility for the DMT as a rule-out test for melanoma - Negative predictive value higher than 99% ...
/PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of DermTech, Inc. (NASDAQ: DMTK) between May 3, 2022...
SHAREHOLDER ALERT: Potential Recovery for DermTech, Inc. (DMTK) Investors ...
NEW YORK, Dec. 14, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor...